Towards Healthcare
Cancer Vaccines Market Size Soars 11.44% CAGR by 2034

Cancer Vaccines Market Opportunities, Challenges and Breakthroughs to Watch

According to market projections, the cancer vaccines sector is expected to grow from USD 11.38 billion in 2024 to USD 33.61 billion by 2034, reflecting a CAGR of 11.44%. The increasing prevalence of cancer, research and development and continuous efforts taken by governments and key stakeholders drive the market's growth.

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global Cancer Vaccines Market Assessment

  • Overview
  • Global Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Preventive Cancer Vaccines
    • Therapeutic Cancer Vaccines
    • Others
    • Others
  • Global Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Cervical Cancer
    • Prostate Cancer
    • Other Indications
  • Global Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Recombinant Cancer Vaccines
    • Viral Vector and DNA Cancer Vaccines
    • Whole-cell Cancer Vaccines
      Others
  • Global Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospitals
    • Government Suppliers
  • Global Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Geography (2021 – 2033)
    • North America
    • Europe
    • Asia-Pacific
    • Latin America
    • Middle East & Africa (MEA)

North America Cancer Vaccines Market Assessment

  • Overview
  • Regional trends
  • North America Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Preventive Cancer Vaccines
    • Therapeutic Cancer Vaccines
    • Others
  • North America Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Cervical Cancer
    • Prostate Cancer
    • Other Indications
  • North America Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Recombinant Cancer Vaccines
    • Viral Vector and DNA Cancer Vaccines
    • Whole-cell Cancer Vaccines
    • Others
  • North America Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospitals
    • Government Suppliers

Europe Cancer Vaccines Market Assessment

  • Overview
  • Regional trends
  • Europe Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Preventive Cancer Vaccines
    • Therapeutic Cancer Vaccines
    • Others
  • Europe Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Cervical Cancer
    • Prostate Cancer
    • Other Indications
  • Europe Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Recombinant Cancer Vaccines
    • Viral Vector and DNA Cancer Vaccines
    • Whole-cell Cancer Vaccines
    • Others
  • Europe Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospitals
    • Government Suppliers

Asia-Pacific Cancer Vaccines Market Assessment

  • Overview
  • Regional trends
  • Asia-Pacific Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Preventive Cancer Vaccines
    • Therapeutic Cancer Vaccines
    • Others
  • Asia-Pacific Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Cervical Cancer
    • Prostate Cancer
    • Other Indications
  • Asia-Pacific Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Recombinant Cancer Vaccines
    • Viral Vector and DNA Cancer Vaccines
    • Whole-cell Cancer Vaccines
    • Others
  • Asia-Pacific Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospitals
    • Government Suppliers

Latin America Cancer Vaccines Market Assessment

  • Overview
  • Regional trends
  • Latin America Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Preventive Cancer Vaccines
    • Therapeutic Cancer Vaccines
    • Others
  • Latin America Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Cervical Cancer
    • Prostate Cancer
    • Other Indications
  • Latin America Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Recombinant Cancer Vaccines
    • Viral Vector and DNA Cancer Vaccines
    • Whole-cell Cancer Vaccines
    • Others
  • Latin America Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospitals
    • Government Suppliers

Middle East and Africa Cancer Vaccines Market Assessment

  • Overview
  • Regional trends
  • Middle East and Africa Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Preventive Cancer Vaccines
    • Therapeutic Cancer Vaccines
    • Others
  • Middle East and Africa Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Cervical Cancer
    • Prostate Cancer
    • Other Indications
  • Middle East and Africa Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Recombinant Cancer Vaccines
    • Viral Vector and DNA Cancer Vaccines
    • Whole-cell Cancer Vaccines
    • Others
  • Middle East and Africa Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospitals
    • Government Suppliers

Company Profiles

  • Generex Biotechnology Corporation
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • Immunocellular Therapeutics, Ltd
  • Vaccinogen, Inc.
  • GlaxoSmithKline plc (GSK)
  • Advaxis Inc.
  • Dynavax Technologies Corporation
  • Merck & Co., Inc.
  • SANPOWER GROUP CO. LTD. (DENDEREON CORPORATION)
  • UbiVac
  • Amgen Inc.

Conclusion & Recommendations

  • Insight Code: 5153
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: May 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

FAQ's

Yes. Vaccines used for treatment are called immunotherapy, treatment vaccines, or therapeutic vaccines. These vaccines prevent the reoccurrence of cancer and the destruction of cancer cells post-treatment, as well as prevent cancer from spreading.

Lung cancer, lymphoma, prostate cancer, ovarian cancer, melanoma, breast cancer, mesothelioma, cervical cancer and reproductive organ cancer.

Research, development, and clinical trials are ongoing to develop combination cancer therapies, oncolytic virus-based vaccines, personalized vaccines, and in situ vaccines or intratumoral therapies.

World Health Organization, National Cancer Institute, National Library of Medicine, Press Information Bureau and Cancer Research Institute.